Notes
2016 US dollars
Reference
Carlson JJ, et al. Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States. Journal of Managed Care and Specialty Pharmacy 24: 29-38, No. 1, Jan 2018. Available from: URL: https://doi.org/10.18553/jmcp.2018.24.1.29
Rights and permissions
About this article
Cite this article
Daratumumab, panobinostat cost effective for MM. PharmacoEcon Outcomes News 795, 10 (2018). https://doi.org/10.1007/s40274-018-4648-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4648-1